Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT04486833 |
| Title | Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib (Acclaim-1) |
| Acronym | Acclaim-1 |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Genprex, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Valkyrie Clinical Trials | RECRUITING | Los Angeles | California | 90067 | United States | Details |
| Rocky Mountain Cancer Centers | RECRUITING | Lone Tree | Colorado | 80124 | United States | Details |
| Carle Cancer Institute | RECRUITING | Urbana | Illinois | 61801 | United States | Details |
| Maryland Oncology Hematology | RECRUITING | Rockville | Maryland | 20850 | United States | Details |
| Millennium Oncology | RECRUITING | Houston | Texas | 77090 | United States | Details |
| Virginia Cancer Specialists | RECRUITING | Fairfax | Virginia | 22031 | United States | Details |